The methanolic extracts of several natural medicines and medicinal foodstuffs were found to show an inhibitory effect on rat lens aldose reductase. In most cases, flavonoids were isolated as the active constituents by bioassay-guided separation, and among them, quercitrin (IC 50 ‫51.0؍‬ m mM), guaijaverin (0.18 m mM), and desmanthin-1 (0.082 m mM) exhibited potent inhibitory activity. Desmanthin-1 showed the most potent activity, which was equivalent to that of a commercial synthetic aldose reductase inhibitor, epalrestat (0.072 m mM). In order to clarify the structural requirements of flavonoids for aldose reductase inhibitory activity, various flavonoids and related compounds were examined. The results suggested the following structural requirements of flavonoid: 1) the flavones and flavonols having the 7-hydroxyl and/or catechol moiety at the B ring (the 3,4-dihydroxyl moiety) exhibit the strong activity; 2) the 5-hydroxyl moiety does not affect the activity; 3) the 3-hydroxyl and 7-O-glucosyl moieties reduce the activity; 4) the 2-3 double bond enhances the activity; 5) the flavones and flavonols having the catechol moiety at the B ring exhibit stronger activity than those having the pyrogallol moiety (the 3,4,5-trihydroxyl moiety).
Aldose reductase as a key enzyme in the polyol pathway is reported to catalyze the reduction of glucose to sorbitol. In normal tissue, aldose reductase has low substrate affinity to glucose, so that the conversion of glucose to sorbitol is little catalyzed. However, in diabetes mellitus, the increased availability of glucose in insulin-insensitive tissues such as lens, nerve, and retina leads to the increased formation of sorbitol through the polyol pathway. Sorbitol does not readily diffuse across cell membranes and the intracellular accumulation of sorbitol has been implicated in the chronic complications of diabetes such as cataract, neuropathy, and retinopathy. These findings suggest that aldose reductase inhibitor prevents the conversion of glucose to sorbitol and may have the capacity of preventing and/or treating several diabetic complications. 1) In the course of our characterization studies on antidiabetic principles of natural medicines, [2] [3] [4] [5] [6] we have found that the methanolic extracts of several natural medicines and medicinal foodstuffs, such as Chrysanthemum (C.) indicum, [7] [8] [9] C. morifolium, 10) Prunus mume, 10) Myrcia multiflora, 3, 6) Centella asiatica, 11) and Salacia (S.) reticulata, S. oblonga, and S. chinensis 12, 13) exhibited potent inhibitory activity against rat lens aldose reductase. By bioassay-guided separation on the above extracts, several flavonoids were isolated as active components. Since the mid.-1970's, several studies on the inhibition of aldose reductase by flavonoids have been reported. [14] [15] [16] However, their structure-activity relationships were not discussed satisfactorily because of the limited number of compounds. In the present study, 94 flavonoids and stilbenes were examined to clarify the further structural requirements of flavonoids for aldose reductase inhibitory activity.
Inhibitory Effects of Several Methanolic Extracts on Rat Lens Aldose Reductase
The methanolic extracts of several natural medicines and medicinal foodstuffs were examined for rat lens aldose reductase inhibitory activity. Among them, the flowers of Chrysanthemum (C.) indicum, [7] [8] [9] C. morifolium (Compositae), 10) and Prunus mume (Rosaceae), 10) the leaves of Myrcia multiflora (Myrtaceae), 3, 6) the aerial parts of Centella asiatica (Umbelliferae), 11) and the stems of Salacia (S.) reticulata, S. oblonga, and S. chinensis (Hippocrateaceae) 12, 13) exhibited potent inhibitory activity as shown in Table 1 .
Preparation of Flavonoids and Related Compounds
From the above-mentioned active extracts, various flavonoid constituents were commonly isolated as active compounds. To clarify the structural requirements of flavonoids for rat lens aldose reductase inhibitory activity, the following flavonoids and related compounds were prepared: tectochrysin (4) and izalpinin (21) from the fruit of Alpinia oxyphylla; 17, 18) (37) , and (2S)-and (2R)-eriodictyol 7-O-b-D-glucopyranosiduronic acids (63, 64) from the flowers of Chrysanthemum indicum; [7] [8] [9] kaempferol 3-O-b-D-glucopyranosiduronic acid (23) from the aerial parts of Centella asiatica; 11) isoquercitrin (33) and quercitrin (35) from the roasted leaves of Apocynum venetum; 19) rutin (38) from the flowers of Sophora japonica; 20) guaijaverin (36) , mearncitrin (51), and desmanthin-1 (56) from the leaves of Myrcia multiflora; 3.66 13) The above natural medicines and medicinal foodstuffs were extracted with methanol under reflux 3 hϫ3 times. a) Extracted with 80% aqueous methanol. myricetin (43) and myricitrin (50) from the stems of Myrica rubra; 21) liquiritigenin (58) and liquiritin (60) from the roots of Glycyrrhiza uralensis; 22) daidzein (66), daidzin (67), genistein (68), and genistin (69) from the seeds of Glycine max 23) ; tectorigenin (70), tectoridin (71), tectorigenin
, and puerarin (76) from the flowers of Pueraria thunbergiana; 24) (ϩ)-catechin (78) and (Ϫ)-epicatechin (79) from the flowers of Camellia japonica; 25) and (Ϫ)-epigallocatechin (80) from Salacia reticulata. 12) Stilbenes were obtained from the rhizome of Rheum undulatum. [26] [27] [28] Apigenin (8), 29) diosmetin (13), 29) kaempferol (22), 29) quercetin (24), 29) 30, 30) and 48 31) were derived by methanolysis of 10, 19, 23, 38, 41, 32) and 54, respectively. The following derivatives were prepared by diazomethane methylation: 9 33) was prepared from 8; pilloin (14) 34) and 15 35) from luteolin (12); rhamnetin (25), 36) tamarixetin (26), 37) 27, 38) ombuine (28), 36, 37) ayanin (29), 37) and 31 39) from 24; rhamnetin 3-O-rutinoside (39), 40) ombuine 3-O-rutinoside (40), 41) 47) and 49 43) were derived by methyl iodide (CH 3 I) methylation of 12, 24, and 43, respectively.
Compounds 59 48) and 62 9) were prepared by enzymatic hydrolysis of 61 and the mixture of 63 and 64 (ca. 1 : 1) with bglucuronidase.
The following flavonoids were purchased from Funakoshi Co., Ltd., (Tokyo, Japan): flavone (1), 7-hydroxyflavone (2), chrysin (3), 4Ј,7-dihydroxyflavone (5), 3Ј,4Ј-dihydroxyflavone (6), 3Ј,4Ј,7-trihydroxyflavone (7), 3-hydroxyflavone (20) , hyperin (34), flavanone (57), fustin (65), and biochanin A (77); from Wako Pure Industries Ltd., (Osaka, Japan): fisetin (42) .
Structural Requirement of Flavonoids and Related Compounds for Rat Lens Aldose Reductase Inhibitory Activity As shown in Table 2 , 3Ј,4Ј-dihydroxyflavone (6, IC 50 ϭ0.37 mM), 3Ј,4Ј,7-trihydroxyflavone (7, 0.30 mM), luteolin (12, 0.45 mM), and luteolin 7-O-b-D-glucopyranoside (17, 0.99 mM) were potent inhibitors among the flavone constituents, while flavone (1, Ͼ100 mM) and tectochrysin (4, Ͼ100 mM) lacked the activity. The activities of flavones lacking the 5-hydroxyl group were equipotent to those of 5-hydroxyl flavones [ex. 7-hydroxyflavone (2, 10 mM)Լchrysin . In addition, the activities of the flavones having a catechol moiety at the B ring (the 3Ј,4Ј-dihydroxyl moiety) were stronger than those of monohydroxyl, mono-or dimethylated compounds [ex. 6 and 7Ͼ5; 12Ͼ8 and 13; 17Ͼ19].
Next, various flavonols, flavanones, and a dihydroflavonol were examined, and the results are shown in Tables 3-5 . Compounds 27 (0.82 mM), quercitrin (35, 0.15 mM), guaijaverin (36, 0.18 mM), and desmanthin-1 (56, 0.082 mM) were found to show potent inhibition, and these results also support the above suggestion. In addition, the activities of the flavonols (having the 3-hydroxyl group) and flavanones (single bond at the 2-3 position) were reduced as compared with their corresponding flavones [ex. 8Ͼkaempferol (22, 10 mM); Glc:
Values in parentheses represent the inhibition (%) at # 30 mM and ## 100 mM.
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Values in parentheses represent the inhibition (%) at # 30 mM and ## 100 mM. Table 6 ), flavan-3-ols (78-80, Table 7 ), and stilbenes (81-94, Table 8 ). Their inhibitory activities were weaker than flavone, flavonol, and flavanone type compounds. Previous study demonstrated the possible relationships of structure to the inhibitory activities of flavonoids: 1) flavones and flavonols having a catechol moiety at the B ring (the 3Ј,4Ј-dihydroxyl moiety) show stronger activity; 2) the 2-3 double bond enhances the activity; and 3) isoflavones and catechins show less activity than flavones. [14] [15] [16] In the pre- Fustin (65) 14
Values in parentheses represent the inhibition (%) at ## 100 mM. 
Values in parentheses represent the inhibition (%) at ## 100 mM.
sent study, our results indicated some additional structural requirements of flavonoids for aldose reductase inhibitory activity: 1) the 5-hydroxyl moiety does not affect the activity; 2) 3-hydroxyl and 7-O-glucosyl moieties reduce the activity; 3) the flavones and flavonols having a catechol moiety at the B ring exhibit stronger activities than pyrogallol type compounds.
In conclusion, quercitrin (35, 0.15 mM), guaijaverin (36, 0.18 mM), and desmanthin-1 (56, 0.082 mM) were found to show potent inhibitory activity. Especially, the activity of 56 was equivalent to that of a commercial synthetic aldose reductase inhibitor, epalrestat (0.072 mM). Some additional structural requirements of flavonoids for the activity were also clarified.
Experimental
The following instruments were used to obtain physical data: electron impact (EI)-MS and high-resolution MS, JEOL JMS-GCMATE mass spectrometer; FAB-MS and high-resolution MS, JEOL JMS-SX 102A mass spectrometer;
1 H-NMR spectra, JEOL EX-270 (270 MHz) spectrometer; HCl-dry MeOH (3.0 ml) was heated under reflux for 2 h. The reaction mixture was poured into ice-water and the whole was extracted with AcOEt. The AcOEt extract was successively washed with saturated aqueous NaHCO 3 and brine, then dried over MgSO 4 powder and filtered. Removal of the solvent from the filtrate under reduced pressure furnished a residue, which was purified by silica gel column chromatography [1 g, n-hexane-AcOEt (1 : 1)] to give apigenin (8, 18 mg, 95%), diosmetin (13, 20 mg, quant.), and kaempferol (22, 20 mg, quant.), respectively. Through a similar procedure, a solution of rutin (38, 2.0 g, 3.28 mmol) in 9% HCl-dry MeOH (30.0 ml) was heated under reflux for 3 h. The reaction mixture was treated in the usual manner to give a residue, which was purified by silica gel column chromatography [50 g, n-hexane-AcOEt (1 : 1)] to give quercetin (24, 950 mg, 96%). A solution of 41 (30 mg, 0.048 mmol) in 9% HCl-dry MeOH (3.0 ml) was heated under reflux for 2 h. The reaction mixture was treated in the usual manner to give a residue, which was purified by silica gel column chromatography [500 mg, n-hexane-AcOEt (2 : 1)] to give 30 (13 mg, 87%). A solution of 54 (30 mg, 0.059 mmol) in 9% HCl-dry MeOH (3.0 ml) was heated under reflux for 1 h. Work-up of the reaction mixture yielded a residue, which was purified by silica gel column chromatography [1 g, n-hexane-AcOEt (1 : 1)] to give 48 (18 mg, 84%).
Compounds 8, 13, 22, and 24 were identified by comparison of the physical data with reported values.
29) The structures of 30 30) and 48 31) were confirmed by the following physical data. C-2Љ), 75.8 (C-5Љ), 76.4 (C-3Љ), 92.2 (C-8), 97.8 (C-6), 100.7 (C-1ٞ) , 6Љ-H), 3.78, 3.88 (3H each, both s, 4Ј, 7-OCH 3 ), 3.89 (6H, s, 3Ј in N,N-dimethylformamide (DMF, 2.0 ml) was treated with methyl iodide (CH 3 I, 0.1 ml) in the presence of sodium hydride (NaH, 10 mg) and the mixture was stirred at room temperature for 12 h. The reaction mixture was poured into ice-water and the whole was extracted with AcOEt. The AcOEt extract was successively washed with saturated aqueous NaHCO 3 and brine, then dried over MgSO 4 powder and the filtrate under reduced pressure furnished a residue, which was purified by silica gel column chromatography [1.0 g, n-hexane-AcOEt (1 : 1)] to give 16 (30 mg, 84%). Through a similar procedure of methylation, quercetin (24, 30 mg, 0.10 mmol) in DMF (2.0 ml) using CH 3 I (0.1 ml) and NaH (10 mg) was stirred at room temperature for 12 h. Work-up and the residue was purified by silica gel column chromatography [1.0 g, n-hexane-AcOEt (1 : 1)] to give 32 (31 mg, 84%). A solution of myricetin (43, 40 mg, 0.13 mmol) in DMF (2.0 ml) using CH 3 I (0.1 ml) and NaH (20 mg) was stirred at room temperature for 12 h. Work-up and the residue was purified by silica gel column chromatography [1.0 g, n-hexane-AcOEt (3 : 1)] to give 49 (48 mg, 95%). Compounds 16, 32, and 49 were identified by comparison of the physical data with reported values. 43, 46, 47) Enzymatic Hydrolysis of 61 A solution of 61 (50 mg, 0.12 mmol) in 0.2 M acetate buffer (pH 5.0, 5.0 ml) was treated with b-glucosidase (20.0 mg, Sigma) and the solution was stirred at 37°C for 12 h. After treatment of the reaction mixture with EtOH, the mixture was evaporated to dryness under reduced pressure and the residue was purified by ordinary-phase silica gel column chromatography [2 g, n-hexane-AcOEt (1 : 1)] to give 59 (29 mg, 93%), which was identified by comparison of its physical data with those of reported values.
30: High-resolution EI-MS

48)
Bioassay
Aldose reductase activity was assayed by the method described in a previous paper. 3, 6, 7, 9, 11) The supernatant fluid of rat lens homogenate was used as the crude enzyme. The incubation mixture contained 135 mM Na, K-phosphate buffer (pH 7.0), 100 mM Li 2 SO 4 , 0.03 mM NADPH, 1 mM DL-glyceraldehyde as a substrate, and 100 ml of enzyme fraction, with or without 25 ml of sample solution, in a total volume of 0.5 ml. The reaction was initiated by the addition of NADPH at 30°C. After 30 min, the reaction was stopped by the addition of 150 ml 0.5 M HCl. Then, 0.5 ml 6 M NaOH containing 10 mM imidazole was added, and the solution was heated at 60°C for 10 min to convert NADP to a fluorescent product. Fluorescence was measured using a fluorophotometer (Luminescence Spectrometer LS50B, Perkin Elmer, England) at an excitation wavelength of 360 nm and an emission wavelength of 460 nm.
